HUDSON, Wis. – Phillips-Medisize, a Molex company, will expand a 380,000-square-foot Little Rock, Ark., facility to include a U.S. Food and Drug Administration-registered manufacturing Center of Excellence for Connected Health and drug delivery devices.
This facility establishes a new manufacturing site for Phillips-Medisize’s medical business, with capabilities for connected devices, filling, drug handling and electronics.
The construction of purpose-built clean room suites, as well as FDA registration and ISO 13485 certification, are scheduled to be complete for its first customer’s production beginning in Q2 2018.
“Phillips-Medisize is excited to align with Molex on the transformation of the Little Rock facility, which will be a Center of Excellence for Connected Health and drug delivery devices, and manufacture products that fit in today’s world of innovative devices,” said Matt Jennings, CEO and president of Philips-Medisize, in a statement. “The facility will have a particular focus on mid- to high-volume diagnostics, medical device and drug delivery systems that integrate electronics and digital applications, and will provide us with the additional space needed to reach our growth objectives over the upcoming years.”
This will be the company’s sixth expansion in the past six years to support long-term growth of its medical contract manufacturing business. These investments demonstrate ongoing support for biopharmaceutical and device customers by providing design, development and manufacturing solutions for both mechanical and connected devices across multiple geographies.